Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

SHA:605077 Revenue

Zhejiang Huakang Pharmaceutical had revenue of 1.29B CNY in the quarter ending June 30, 2026, with 23.35% growth. This brings the company's total for the last twelve months to 4.80B, up 44.89% year-over-year. In the year 2025, Zhejiang Huakang Pharmaceutical had annual revenue of 4.19B with 49.15% growth. That makes Zhejiang Huakang Pharmaceutical the 9,214th largest company in the world by revenue and 1,445th in China.

• Revenue (ttm): 4.80B
• Revenue Growth: +44.89%
• P/S Ratio: 0.66
• Revenue / Employee: 2.14M
• Employees: 2,248
• Market Cap: 3.19B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Liquid Sugar, Alcohol and Other Products 2.06B 49.6%
• Crystal Sugar Alcohol Products 1.98B 47.7%
• Unallocated Other 112.46M 2.7%

By Geography

Chart

• China 2.80B 67.4%
• Overseas 1.36B 32.6%

Fiscal year ended Dec 31, 2025 See the full SHA:605077 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.19B	1.38B	49.15%
Dec 31, 2024	2.81B	25.74M	0.93%
Dec 31, 2023	2.78B	582.67M	26.48%
Dec 31, 2022	2.20B	606.01M	38.02%
Dec 31, 2021	1.59B	274.36M	20.79%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error